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ABSTRACT The G-protein coupled receptor CCR5 is the main co-receptor for macrophage-tropic HIV-1 strains. I have built
a structural model of the chemokine receptor CCR5 and used it to explain the binding and selectivity of the antagonist
TAK779. Models of the extracellular (EC) domains of CCR5 have been constructed and used to rationalize current biological
data on the binding of HIV-1 and chemokines. Residues spanning the transmembrane region of CCR5 have been modeled
after rhodopsin, and their functional significance examined using the evolutionary trace method. The receptor cavity shares
six residues with CC-chemokine receptors CCR1 through CCR4, while seven residues are unique to CCR5. The contribution
of these residues to ligand binding and selectivity is tested by molecular docking simulations of TAK779 to CCR1, CCR2, and
CCR5. TAK779 binds to CCR5 in the cavity formed by helices 1, 2, 3, and 7 with additional interactions with helices 5 and
6. TAK779 did not dock to either CCR1 or CCR2. The results are consistent with current site-directed mutagenesis data and
with the observed selectivity of TAK779 for CCR5 over CCR1 and CCR2. The specific residues responsible for the observed
selectivity are identified. The four EC regions of CCR5 have been modeled using constrained simulated annealing simulations.
Applied dihedral angle constraints are representative of the secondary structure propensities of these regions. Tertiary
interactions, in the form of distance constraints, are generated from available epitope mapping data. Analysis of the 250
simulated structures provides new insights to the design of experiments aimed at determining residue-residue contacts
across the EC domains and for mapping CC-chemokines on the surface of the EC domains.
INTRODUCTION
A critical step in cellular entry by HIV-1 is the binding of
the viral envelope protein gp120 to chemokine receptors on
surface of immune cells (Hoffman et al., 1999; Kolchinsky
et al., 1999; Rizzuto et al., 1998; Wu et al., 1996). The
CC-chemokine receptors CCR5 and CXCR4 are the major
co-receptors for R5 and X4 virus strains, respectively
(Berger et al., 1998; Robertson et al., 2000). CCR5 has been
the target of anti-HIV-1 strategies for disrupting the inter-
action with the HIV-1 envelope protein gp120. Studies
suggest that gp120 binds preferentially to the N-terminus of
CCR5 (Dragic et al., 1998; Farzan et al., 1998), and that the
second extracellular region is mostly responsible for the
binding of the endogenous chemokines peptides (Samson et
al., 1997). The two domains are not clearly separated,
because some single point mutations in the N-terminus can
also abolish the binding of chemokines (Blanpain et al.,
1999a). HIV-1 and chemokines mainly interact with the
extracellular (EC) regions of CCR5, while small synthetic
ligands mostly bind to residues of the transmembrane (TM)
region (Dragic et al., 2000).
Chemokine receptors belong to the rhodopsin family of
G-protein coupled receptors (GPCR) characterized by a
heptapeptidic helical fold (7-TM) spanning the plasma
membrane (Fig. 1). Modeling of GPCR has at its disposal
the 2.8 Å resolution structure of bovine rhodopsin (Palczew-
ski et al., 2000) whose 7-TM motif has been proven valid
for other receptors in its family as well (Elling et al., 1997;
Mizobe et al., 1996). However, local structural motifs, such
as those seen in helices of rhodopsin that contain Gly and
Pro (Palczewski et al., 2000), need to be reexamined in the
context of CCR5. Given the relative simplicity of the helical
fold and 30% sequence identity with rhodopsin in the
transmembrane core region, it should be possible to gener-
ate models where 80% of the C atoms are within 3.5 Å
of their correct positions (Sanchez and Sali, 1999). Protein
models obtained at such resolution have been able to cor-
rectly predict the location of binding sites and the size of the
ligands (Sanchez and Sali, 1999). To this extent, theoretical
GPCR models based on a low-resolution template (Unger et
al., 1997; Baldwin et al., 1997) before the x-ray structure
have been successfully used in designing experiments for
structure validation (Lu and Hulme, 2000; Mizobe et al.,
1996; Zhou et al., 1994), determining ligand binding sites
(Metzger et al., 1996; Simpson et al., 1999; Strader et al.,
1994), and formulating hypotheses on mechanisms of re-
ceptor activation (Ballesteros et al., 1998; Cotecchia et al.,
2000; Flanagan et al., 1999; Javitch et al., 1997, 1998).
I have used the x-ray structure of rhodopsin, in combi-
nation with homology techniques, to derive a structural
model of the transmembrane region (TM) of CCR5, and
then applied the evolutionary trace method (Lichtarge et al.,
1996) to compare the residues of the receptor cavity with
those of either distantly or closely related homologs. Evo-
lutionary tracing has been successful in identifying func-
tionally important residues across different protein families
(Johnson and Church, 2000; Sowa et al., 2000). When
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applied to CCR5, the tracing readily isolates residues of the
receptor cavity that can either bind small synthetic ligands
or function as selectivity filters among closely related CC-
chemokine receptors. To test this hypothesis, I have docked
the antagonist TAK779 (Baba et al., 1999) to CCR5 and
compared its binding mode with available experimental
data. The selectivity of TAK779 for CCR5 has been previ-
ously measured against closely related receptors and the
binding site has been probed using site-directed mutagene-
sis (Baba et al., 1999; Dragic et al., 2000). Simulations have
been carried out using an automated docking protocol
(Meng et al., 1992) used in docking simulations of opioid
ligands (Subramanian et al., 1998, 2000). In that work, the
docking procedure, in conjunction with mutagenesis data,
provided binding modes in agreement with structure-activ-
ity relationship (SAR) of opioid ligands and explained, in
part, the observed selectivity. In this work I show that the
docking simulations not only are consistent with the mu-
tagenesis data, but also suggest a rationale for the selectivity
of TAK779 for CCR5, as compared with the chemokine
receptors CCR1 and CCR2. The results show a conserved
region of the binding pocket that may function as a binding
locus for chemokine antagonists that share a common am-
monium group. Nonconserved residues in helices TM3,
TM5, and TM6 would impart receptor selectivity. The
docking results outline specific residues that can be targeted
by site-directed mutagenesis studies for validation of the
proposed binding mode.
The importance of the extracellular (EC) regions in bind-
ing and recognition of chemokines and the HIV-1 envelope
glycoprotein gp120 makes it paramount to include such
regions in the modeling effort. Close proximity among the
EC domains is likely, due to the presence of two disulfide
bonds, one linking the N-terminus to the third extracellular
loop (EL), EL3, and a second between EL1 and EL2 (Blan-
pain et al., 1999b) (Fig. 1). Indirect information on the 3-D
arrangement of the extracellular regions can be inferred
from the mapping of epitope residues recognized by mono-
clonal antibodies (mAbs). The antibody mAb-2D7 recog-
nizes residues in both EL1 and EL2 (Lee et al., 1999), while
mAbs PA9 and PA14 bind to amino acids in both the
N-terminus and EL2 (Olson et al., 1999).
Modeling of GPCR has been mostly applied to residues
in the transmembrane region, and considerably less work
has been done on the N-terminus and loops connecting the
TM helices (Luo et al., 1997; Paterlini et al., 1997; Moro et
al., 1999; Odile-Colson et al., 1998; Pogozheva et al., 1998).
Modeling of the extracellular regions of GPCR is challeng-
ing because of limited homology with known structures and
of limitations of current loop modeling techniques. The
combination of low sequence identity with rhodopsin and
short loop length makes it difficult to match the EC regions
with homologous segments of known structure using data-
base search programs (Altschul et al., 1997). The three
extracellular loops are generally 10–30 residues in length,
and thus behind the applicability of current loop modeling
tools (Van Vlijmen and Karplus, 1997; Li et al., 1999, Fiser
et al., 2000). Loop modeling is typically applied to isolated
loops of globular proteins, while loops of GPCR most likely
contain numerous tertiary interactions, as demonstrated by
rhodopsin. The tertiary fold of a protein is difficult to
predict computationally without the aid of geometrical con-
straints (Zhang et al., 2002a). In the case of membrane
proteins, distance constraints are usually obtained using
EPR and fluorescence spectroscopies, or by disulfide bond
engineering. For example, EPR spectroscopy has been ex-
FIGURE 1 Schematic representation of
the CCR5 sequence. Gray rectangles outline
residues in the 7-TM region, TM1 through
TM7, and helix 8. EL and IL denote extra-
cellular and intracellular loop regions, re-
spectively. Disulfide bridges between C20
and C269 and C101 and C178 are shown as
lines connecting these cysteines. Gray circles
denote conservation of strong groups in
CCR1 through CCR5. Gray circles with
heavy outlines denote identical residues in
CCR1 through CCR5. Black circles denote
highly conserved residues in the rhodopsin
family of GPCR. For ease of comparison
with other GPCR, residues are numbered
using the highly conserved residues as refer-
ence (Ballesteros and Weinstein, 1995). N:
1.50 (TM1); D: 2.50 (TM2); R: 3.50 (TM3);
W: 4.50 (TM4); P: 5.50 (TM5); P: 6.50
(TM6); P: 7.50 (TM7).
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tensively used to map interactions among the three intracel-
lular loops of rhodopsin (Hubbell et al., 2000). Spectrosco-
py-derived distances are not available for CCR5. However,
indirect distance information can be inferred from epitope
mapping results. A previous study on the sensitivity of
mAbs to the tertiary structure of their targets has shown that
antibodies recognize a region within a 15 Å radius of the
epitope residues (Burritt et al., 1998). I have, therefore,
transformed the epitope mapping data of CCR5 into dis-
tance constraints between the different EC regions to create
tertiary contacts among the EC domains.
I have combined homology information, tertiary con-
straints derived from available experimental data, and ab
initio computational tools to model the 95 residues of the
extracellular regions of CCR5, which vary in length from a
32-residue-long N-terminus to the 13 residues of EL1. Sec-
ondary structure prediction methods were first used to ob-
tain secondary structure propensities of the individual ex-
tracellular region. Additional searches for homologous
sequences in the PDB protein data bank (Berman et al.,
2000) provided validation of the prediction results and
initial structural templates for each of the four domains.
Conformations of the extracellular regions generated in this
fashion were subjected to constrained simulated annealing
simulations and analyzed based on conformational energy,
structural variability, and average physical characteristics.
The addition of tertiary constraints results in clusters of
critical aromatic and acidic residues previously implicated
in the binding of chemokines and gp120 (Blanpain et al.,
1999a; Howard et al., 1999; Rabut et al., 1998; Zhou et al.,
2000). The EC models are used to explain the sensitivity of
these residues to mutation and suggest specific residue-
residue interactions that could be validated by site-directed
mutagenesis and sites for mapping the interaction of the
chemokines with CCR5.
MATERIALS AND METHODS
CCR5 receptor model
The CCR5 sequence (Accession number P51681) was scored against the
SWISSPROT database (Bairoch and Apweiler, 2000) using BLAST2.0
(Altschul et al., 1997) with the BLOSUM62 matrix and standard parame-
ters in the Biology Workbench (http://workbench.sdsc.edu) (Subramaniam,
1998). Sequences were aligned using CLUSTALW (Thompson et al.,
1994). The suite of programs PERSCAN (Donnelly et al., 1994) was used
to identify residues located in the transmembrane from a set of 50 nonre-
dundant sequences with the highest homology to CCR5 (see Table 1).
Sequence identity of the 50 sequences with CCR5 was between 28% and
99% for residues in the transmembrane region.
The length of the CCR5 helices was determined by first considering a
minimum length of 18 residues in the core of the lipid bilayer. Up to seven
additional residues at each end were then added to allow extension of the
helices into the lipid polar head regions (White, 1994). Criteria for finding
the end of the helices were based either on the -helical index (AP index)
(Donnelly et al., 1994), calculated using the 50 sequences in Table 1, or on
sequence analysis of these regions.
Criteria from sequence analysis, homology to rhodopsin, and the pres-
ence of either Gly or Pro near the ends were used to determine the length
of the TM helices. Glycine and proline residues are indicators of helix
termination or initiation in globular helices (Prieto and Serrano, 1997;
Viguera and Serrano, 1999) and have a similar function in rhodopsin as
well (Palczewski et al., 2000). Residues modeled in the -helical confor-
mation are shown in Fig. 1.
The set of 50 unique sequences with the highest sequence homology to
CCR5 (Table 1) was also used to compare the orientation of the 7-TM
bundle of CCR5 with that of the average template (Baldwin et al., 1997)
and of rhodopsin. Calculations of the helix orientations using criteria based
on the periodicity of conserved residues (Donnelly et al., 1994) were within
20° of those obtained using periodicity of substitutions (Overington et al.,
1992; Donnelly et al., 1994).
Structural homologs of sequences in the EC regions were obtained by
searching the PDB database (Berman et al., 2000) using BLASTP2.0 or
PSI-BLAST with either PAM30 or PAM70 matrices. Expectation values of
the hits varied from E  0.0002 to E  107. The searches produced from
3 to 12 structures for each sequence searched. Sequences found in this
fashion were then used in MODELLER4 (Sali and Blundell, 1993) using
the “model” routine to generate initial loop structures. Structures 1IRK
(residues 1150–1163), 1PFC (residues 390–401), 1UWB (residues 274:
B-283:B), and 2BPA (residues 120:2–131:2) were used as templates for the
N-terminus. Initial conformations of EL1 made use of structures 1TIA
(residues 12–19), 1BGY (residues 31:O-50:O) and 1TMF (residues 206–
212 of chain 1). Structures used for EL2 were 1AVQ (residues 178–186 of
chain A), 1HRA (residues 32–34), and 2TS1 (residues 248–257). Struc-
tures used for EL3 were 1ARP (residues 112–128), 17AJ (residues 266–
273) and 2MEV (residues 140–146). Intracellular loop regions were built
using the Search Loop module of the InsightII program (InsightII, 2002.
Accerlys Inc., San Diego, CA).
Prediction of the secondary structure of the loops residues was obtained
using the protein prediction tool PELE, as provided by the Biology Work-
bench (Subramaniam, 1998). The method compares predictions from seven
major algorithms and determines secondary structure based on the mini-
mum consensus for each amino acid.
Side chain rotamers were generated using a backbone-dependent rota-
mer procedure (Dunbrack and Karplus, 1993). The AMBER5.0 (Case et
al., 1995) suite of programs was used for energy minimization and simu-
lated annealing simulations. The model of the transmembrane region was
subjected to energy minimization followed by 500 ps of molecular dynam-
ics (MD) simulation at 300 K, during which positional restraints applied to
backbone atoms were gradually lowered from 2 to 0.1 kcal/mol-Å2. The
structural quality of the model was checked using PROCHECK with 94%
of the residues in the most favored allowed helical region and remaining
6% in the additionally allowed helical region (Laskowski et al., 1993). Side
chain 1 and 2 angles were found in their most favorable regions without
stereochemical conflicts.
Structural models of the TM regions of receptors CCR2 and CCR1 were
constructed from the CCR5 template by replacing the nonconserved side
chains using SQWRL (Dunbrack and Karplus, 1993), followed by energy
minimization.
Side chain accessibility areas of the amino acids were calculated with
the program ACCESS as a percentage compared with that measured for
that residue in an extended Ala-Xxx-Ala tripeptide (Hubbard and Thorn-
ton, 1993).
Structures of the EC regions were generated using a simulated annealing
procedure consisting of fast heating to 1200 K, cooling to 300 K up to 30
ps, and constant temperature for an additional 70 ps, followed by energy
minimization. The backbone dihedral angle  (C-N-C-C) of all residues
except Gly were restricted to negative values during annealing and addi-
tional constraints were imposed to maintain trans- bonds for non-Pro
residues and the correct chirality of the C carbons. Constraints made use
of a flat well potential function with a force constant of 32 kcal/mol/deg2
for angle constraints and 10 kcal/mol-Å 2 for distance constraints. A similar
protocol was used to generate a structure of the intracellular loops. Resi-
dues in the transmembrane region were kept in their initial conformation
using the belly option of SANDER during the annealing procedure. A set
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of 250 structures of the EC regions was obtained in this fashion. Clustering
of structures based on RMSD was obtained using PADRE (Stahl, M. T.,
and W. P. Walters. 1995. PADRE. Population analysis and duplicate
removal (available by ftp from ccl.osc.edu).
Modeling of TAK779
The geometry of TAK779 was optimized using molecular orbital ab initio
methods at the HF/6–31G* level using the Gaussian98 program package
(Frisch et al., 2001). Partial atomic charges were obtained using the
restrained electrostatic potential (RESP) charge fitting formalism (Bayly et
al., 1993). Force field parameters were adapted from similar chemical
groups found in the Cornell et al. (1995) force field (parm96.dat of
AMBER5.0).
Ligand docking
Docking of the minimum energy structures of TAK779 to the model-built
TM domain of CCR5, CCR1, and CCR2 was performed using the auto-
mated docking procedure DOCK3.5 (Meng et al., 1992) by following a
previously described protocol (Subramanian et al., 1998). The docking
cavity was generated using SPHGEN by generating spheres from the
solvent-accessible molecular surface of the receptor cavity. Clusters con-
taining 121 spheres for CCR5, 90 for CCR1, and 74 for CCR2 were
generated in this fashion. A maximum of six steric overlaps were allowed
during the generation of docking orientations. The predicted orientations
were scored individually based on the empirical evaluation of the electro-
static and van der Waals energy contributions.
Refinement of the initial receptor-ligand complex was obtained by in
vacuo energy minimization (0.001 kcal/mol rms deviation) followed by
MD simulations up to 1 ns. A 3.0 kcal/mol positional constraint was
applied to the receptor backbone atoms, the cutoff for nonbonded interac-
tions was 8 Å, and the dielectric constant was 4. The temperature of the
system was maintained at 298 K with a 0.2 ps coupling constant.
RESULTS
Modeling and characterization of the
transmembrane region of CCR5
The model of the transmembrane region of CCR5 is based
on the x-ray structure of rhodopsin (Palczewski et al., 2000)
and makes use of a previous sequence analysis of 493
GPCR (Baldwin et al., 1997) to determine the average
orientation of the helices in the 7-TM bundle with respect to
the lipid environment and to outline possible discrepancies
between rhodopsin and CCR5. Homology between CCR5
and rhodopsin is lower near the extracellular medium, and
variations in these regions may result in a different length
and/or different orientation of the helices at these ends. The
sequence of CCR5 is schematically shown in Fig. 1, where
highly conserved residues are numbered according to the
convention of Ballesteros and Weinstein (1995). A set of 50
sequences with the highest sequence identity to CCR5 was
used in the comparison (Table 1).
Calculations of the lipid-facing direction of helices TM1,
TM3, TM4, and TM6 were in good agreement with those
obtained from a larger set and from the x-ray structure of
rhodopsin. The orientation of residues at the extracellular
end of TM2 and TM5, while in agreement with that ob-
tained by Baldwin et al. (1997), deviated by 100° from
rhodopsin. This discrepancy originates from bulges in TM2
and TM5 that alter the helical periodicity, thus exposing
residues to the lipid environment that would otherwise face
the bundle’s interior. The bulge in TM5 of rhodopsin is near
a conserved proline, flanked by large hydrophobic residues
in the F212IIPLIV218 region. The corresponding CCR5 frag-
ment, L203VLPLLV209, has a similar amino acid composi-
tion and is likely to adopt a similar conformation. By using
the TM5-rhodopsin template, residues K191 and T195 of
TM5 orient toward residue T259 of TM6. They would not
face each other if TM5 is modeled as an ideal helix. Previ-
ous studies have shown that residues at these three positions
are proximal to each other, as they can form interhelical
disulfide bonds when mutated to Cys in rhodopsin and the
tachykinin NK1 receptors (Elling et al., 2000; Struthers et
al., 1999). Similarly, replacement with His creates a zinc
binding site in both the NK1 and kappa opioid receptors
(Thirstrup et al., 1996; Elling et al., 1997). The NK1,
kappa opioid, and CCR5 receptors all have an amino acid
composition similar to rhodopsin near the conserved Pro.
Helix 5 of CCR5 was therefore modeled using the rho-
dopsin template.
Replacement of the rhodopsin side chains with those of
CCR5 resulted in steric conflict between residues T82 and V83
of TM2 and L107 in TM3. Furthermore, the orientation of the
C-terminal residues of TM2 did not agree with that predicted
by the Fourier transform analysis of the 50 helices or with the
previous sequence analysis of GPCR (Baldwin et al., 1997).
Closer analysis of helix 2 showed that T82 and V83 replace
residues G89 and G90 of rhodopsin at a location where TM2
and TM3 cross and interact with the closest packing. This type
of interaction, where large side chains in one helix pack against
the Gly backbone of the other helix, is often found in mem-
brane proteins (Javadpour et al., 1999). In rhodopsin, packing
is achieved by a local distortion of the helical conformation at
these sites. Replacement of the two glycines with the larger
CCR5 side chains within this structural motif results in atomic
overlap. The extracellular portion of TM2 was therefore mod-
eled by changing the dihedral angles of the L80-P84 fragment
according to average values observed in Pro-containing -he-
lices (Ne´mety et al., 1992; Sankararamakrishnan and Vish-
veshwara, 1992). The changes in the torsion angles relieved the
atomic overlap between TM2 and TM3 and resulted in an
orientation of the C-end residues of TM2, in agreement with
both the Fourier analysis and the previous sequence analysis of
GPCR (Baldwin et al., 1997). A comparison of dihedral angles
in this region between CCR5 and rhodopsin is given in Table
2. The modeled TM2 helix is likely to be valid for those
GPCRs that contain the highly conserved TM2-Pro and lack
the Gly-Gly motif. Templates for helix 7 and its adjoining helix
8 were taken from the x-ray structure of rhodopsin, based on
high sequence homology in both helical regions. Helix 7 of
rhodopsin is irregular, containing four residues in the 310
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conformations, flanked by -helical segments. The model of
the transmembrane region of CCR5 is shown in Fig. 2.
The peptide subfamily of GPCR (Kolakowski, 1994)
contains receptors that bind a disparate array of peptides,
such as angiotensin, bradykinin, opioid, somatostatin, and
chemokines. I have used evolutionary tracing (Lichtarge et
al., 1996) to locate functionally important residues in this
receptor family based on sequence conservation with the
goal of uncovering amino acids in CCR5 that are responsi-
ble for binding and selectivity of ligands. Evolutionary trace
analysis was restricted to the transmembrane regions, where
the accuracy of the model template is sufficient for this type
of analysis. The sequences of 50 highly homologous recep-
tors (Table 1) were chosen for the comparison and den-
dograms were constructed by including only residues in the
transmembrane region. The resulting phylogenetic tree (Fig.
3 A) is similar to the one generated with the full sequence
(not shown), thus suggesting a functional specificity for the
TM residues. Results from the tracing were visualized using
surface area accessibility plots of the TM regions (Fig. 3 B).
The periodic pattern mirrors the helical periodicity, with
maxima occurring at residues on the outside of the TM
bundle, and minima at residues located either at helical
interfaces or the interior. The plot readily identifies con-
served and CCR5-specific residues of the receptor cavity.
The minima observed for residues TM1-N48, TM2-D76,
TM3-I116, TM5-L207, TM6-Y244, and TM7-N293 corre-
spond to a network of interacting residues that define the
bottom of the receptor cavity. Of these, N48 (1.50, using the
numbering of Ballesteros and Weinstein, 1995), D76 (2.50),
and N293 (7.49) are highly conserved in the rhodopsin
family of GPCR (36% identity cutoff in Fig. 3 A), either Phe
or Tyr is found at position Y244 (6.44), and large hydro-
phobic residues occupy positions I116 (3.40) and L207
(5.51) (Fig. 3 B). The trace obtained with a 76% identity
cutoff shows only one additional conserved residue, TM1-
Y37 (1.39). Three additional conserved residues at 92%
identity, P34 (1.36), W86 (2.60), and C290 (7.46), are found
in both chemokines and angiotensin receptors. The highly
conserved TM6-Trp (6.48) of GPCR, W248 in CCR5, ap-
pears only in the trace at 92% identity, because of sequence
variations in CCR7 and the purinergic receptor. An addi-
tional six residues are conserved in receptors CCR1 through
TABLE 1 G-protein coupled receptor with high sequence
homology to human CCR5
Receptor % Identity* Database Reference†
Chemokines
CCR5, human 100 CKR5_HUMAN
CCR5, rhesus macaque 87 CKR5_MACMU
CCR5, sooty mangabey 87 CKR5_CERTO
CCR5, green monkey 86 CKR5_CERAE
CCR5, chimpanzee 98 CKR5_PANTR
CCR5, gorilla 98 CKR5_GORGO
CCR5, baboon 99 CKR5_PAPHA
CCR5, rat 84 CKR5_RAT
CCR5, mouse 84 CKR5_MOUSE
CCR1, human 66 CKR1_HUMAN
CCR1, rhesus macaque 64 CKR1_MACMU
CCR1, mouse 63 CKR1_MOUSE
CCR2, human 86 CKR2_HUMAN
CCR2, mouse 86 CKR2_MOUSE
CCR3, human 63 CKR3_HUMAN
CCR3, resus macaque 63 CKR3_MACMU
CCR3, green monkey 63 CKR3_CERAE
CCR3, mouse 68 CKR3_MOUSE
CCR4, human 60 CKR4_HUMAN
CCR4, mouse 59 CKR4_MOUSE
CCR6, human 40 CKR6_HUMAN
CCR7, human 40 CKR7_HUMAN
CCR7, mouse 40 CKR7_MOUSE
CCR8, human 49 CKR8_HUMAN
GPR13, human 50 GPRD_HUMAN
GPR13, rat 56 GPRD_RAT
GPR-96, human 43 GC96_HUMAN
VQ31, capripoxvirus 42 VQ31_CAP
CXCR2, human 40 IL8B_HUMAN
CXCR3-human 39 CCR3_HUMAN
CXCR4-human 37 CCR4_HUMAN
GPR2, human 35 GPR2_HUMAN
RDC1, human 33 RDC1_HUMAN
EBV-induced 32 EBI2_HUMAN
Bradykinin
B2 29 BRB2_HUMAN
Angiotensin
Type 1B, human 36 AG2S_HUMAN
Type 2, human 33 AG22_HUMAN
Type 1-A 35 AG2R_HUMAN
Type 1-B 35 AG2S_MOUSE
Orphan 32 APJ_HUMA
Opioid
, human 30 OPRK_HUMAN
, human 28 OPRM_HUMAN
, human 28 OPRD_HUMAN
Nociceptin, human 29 OPRX_HUMAN
Somatostatin
SSR1, human 32 SSR1_HUMAN
SSR3, human 32 SSR3_HUMAN
SSR4, human 34 SSR4_HUMAN
SSR5, human 33 SSR5_HUMAN
Purinergic
P2Y5, human 30 P2Y5_HUMAN
P2Y9, human 28 P2Y9_HUMAN
*% Identity for 203 residues of the transmembrane region.
†SWISSPROT (Bairoch and Apweiler, 2000).
TABLE 2 Backbone dihedral angle comparison between
modeled CCR5 and rhodopsin at the extracellular end of the
second transmembrane helix
CCR5 Rhodopsin*
Residue  	 Residue  	
Leu-80 63 36 Val-87 47 39
Leu-81 72 18 Phe-88 102 49
Thr-82 87 22 Gly-89 61 58
Val-83 59 49 Gly-90 92 58
Pro-84 51 32 Phe-91 59 24
Angles are in degrees.
*Palczewski et al., 2000.
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CCR5 (residues L33 (1.35), Y108 (3.32), L203 (5.47),
Y251 (6.51), E283 (7.39), and H289 (7.45)), and the re-
maining seven residues are unique to CCR5 (Fig. 3 B).
Automated docking simulations of TAK779
to CCR5
The antagonist TAK779 (Fig. 4) binds with high affinity to
CCR5, but its affinity is 20-fold lower for CCR2 and it
does not bind to CCR1 (Baba et al., 1999). I have used a
previous automated docking protocol (Subramanian et al.,
1998, 2000) to simulate the binding of TAK779 to CCR5,
CCR2, and CCR1. Computed docking orientations were
sorted based on their docking scoring energy. Docking
configurations of TAK779 with energies within 10 kcal/mol
from the energy minimum showed interactions of the ben-
zyl-pyran-ammonium group with helices in TM1, TM2, and
TM7, and close contact of the ammonium nitrogen with
E283. The methylphenyl-benzocycloheptenyl moiety
mainly interacted with residues in TM3, TM5, and TM6.
A docked structure with the shortest distance between the
basic nitrogen and the carboxyl oxygen atoms of E283 was
selected from the ensemble of low-energy orientations and
used in MD simulations to further refine the receptor-ligand
complex. The resulting docking configuration (Fig. 5 and
Table 3) was compared with a previous site-directed mu-
tagenesis study of the binding of TAK779 to CCR5. Resi-
dues of the binding pocket were defined using a 5 Å cutoff
from TAK779. As shown in Table 3, the docking mode
contains several residues implicated in the binding of
TAK779 (Dragic et al., 2000). In that study, putative bind-
ing residues were identified based on a change of 20% or
higher in the efficacy of TAK779 to block HIV-1 entry.
Comparison with the docking results shows that the major-
ity of such residues have been found by the docking proce-
dure. Such residues include E283 in TM7 and neighboring
aromatic residues TM1-Y37, TM2-W86, and TM3-Y108.
Interactions of TAK779 with TM5 and TM6 included TM5-
T195 and I198 in TM5, and Y251, N252, and L255 in TM6.
By comparison, mutagenesis data suggest ligand interaction
at I198 (20% change), but a negligible contribution from
T195 and L255 (Table 3). Data are not available for Y251
and N252 because mutation of these two amino acids to Ala
resulted in poor receptor expression (Dragic et al., 2000).
The majority of the CCR5 residues that form the binding
pocket of TAK779 are also found in receptors CCR1
through CCR4, suggesting that only a few, nonconserved
residues are responsible for the selectivity of TAK779.
Specifically, selectivity could originate from some of the
seven CCR5-unique residues identified by the trace analysis
(Fig. 3 B). This hypothesis was tested by docking simula-
tions of TAK779 to CCR2 and CCR1. Structural models of
receptors CCR2 and CCR1 were constructed from the
CCR5 template by replacing the nonconserved side chains
using the backbone-dependent rotamer procedure of Dun-
brack and Karplus (1993). Docking of TAK779 to CCR2
resulted in several orientations where the ammonium group
of TAK779 was 6 Å from the conserved glutamate in
TM7 (7.39). However, most of these structures lay above
the TM region without making appreciable interactions with
the CCR2 binding pocket. The results suggest that the
transmembrane region of CCR2 cannot accommodate
TAK779. Manual docking of TAK779 in an orientation
similar to that of Fig. 5 resulted in atomic overlap, due to
steric clash between TAK779 and R206 in TM5 and F116
and Y124 in TM3. CCR5 contains smaller amino acids at
these positions. Position 5.42 is Arg (R206) in CCR2 and Ile
(I198) in CCR5, while residues F116 (3.28) and Y124
FIGURE 2 Structural model of the
transmembrane and intracellular re-
gions of CCR5. Shown in red are
aromatic and acid residues conserved
in receptors CCR1 through CCR5
(Y37 (1.39), W86 (2.60), Y108
(3.32), Y251 (6.51), and E283
(7.39)). An adjacent cluster consist-
ing of conserved (F79 (2.53), W248
(6.48)) and CCR5-specific (H289
(7.45), F112 (3.36)) aromatic resi-
dues is shown in green. Residues
Y37, W86, Y108, and E283 are part
of the binding pocket for TAK-779.
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FIGURE 3 Analysis of the transmembrane region
of CCR5. (A) Sequence identity dendogram of the
50 GPCR in Table 1. Only residues of the trans-
membrane region were included in the comparison.
Sequences are denoted using their SWISSPROT da-
tabase entry names. Percent identity values indicate
partition identity cutoff used in the trace analysis.
The dendogram was generated using the DRAW-
GRAM option in the Biology Workbench (http://
workbench.sdsc.edu). (B) Solvent accessibility sur-
face area plots of residues in the TM region.
Sequences are shown in the direction from the ex-
tracellular (left) to the intracellular (right) side. Res-
idues that orient toward the receptor cavity are la-
beled according to the percent sequence identity
using the same symbols as in A. Residues of TM4
are not part of the receptor cavity. Circled star sym-
bols refer to residues common to CCR5 and recep-
tors CCR1 through CCR4. Star symbols denote res-
idues unique to CCR5. Surface areas are given as a
percentage compared to the same residues in an
Ala-Xxx-Ala peptide (Hubbard and Thornton,
1993).
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(3.36) of CCR2 correspond to L104 and F112 of CCR5,
respectively. Docking simulations of TAK779 to CCR1
resulted in some orientations similar to those of CCR5, but
the docking scoring energy was high, suggesting residual
atomic clashes in the binding region. MD simulations of
TAK779 to CCR1 starting from a docked orientation similar
to that of Fig. 5 resulted in the methylphenyl-benzocyclo-
heptenyl group outside the pocket defined by the TM3,
TM5, and TM6 helices. Amino acid comparison shows that
two tyrosines at positions 3.33 and 3.37 of CCR1 (Y114 and
Y118, respectively) are replaced by Phe in CCR5 (F109 and
F113, respectively). Other positions involve residues of
similar size, such as 6.55 (L255 in CCR5 and I259 in
CCR1) and 5.42 (I198 in CCR5 and L203 in CCR1). Ap-
parently, replacing Phe with Tyr is sufficient for the ob-
served displacement from the pocket of CCR1 during the
MD simulation.
Modeling and characterization of extracellular
and intracellular regions
Modeling of the extracellular regions was performed in two
steps. In the first step, information on secondary structure
propensity was gathered. In the second step, each region
was assembled sequentially into the model. Tertiary con-
FIGURE 4 Chemical structure of TAK779 (N,N-dimethyl-N-(4[[[2-(4-
methylphenyl)-6,7-dihydro-5H-benzocyclohepten-8-yl]carbon-yl]benzyl]-
tetrahydro-2H-pyran) (Baba et al., 1999).
FIGURE 5 Orientation of TAK779 in the TM re-
gion of CCR5 after 1 ns MD simulations. Side
chains within 5 Å of TAK779 are shown with a stick
representation. Residues in red have previously been
implicated in TAK779 binding (Dragic et al., 2000.
Residues in green are side chains whose substitution
with Ala did not interfere with TAK779 antiviral
activity.
TABLE 3 Residues of CCR5 within a 5 Å cutoff of TAK779,
as found in Fig. 5, and comparison with previous site-directed
mutagenesis results
CCR5 % Viral Entry*
WT 0
L33 40
Y37 75
W86 80
L104 15
Y108 100
F112 10
T195 5
I198 20
L255 5
E283 30
*% Change in the efficacy of TAK779 to inhibit viral entry upon mutation
of these residues to alanine (Dragic et al., 2000).
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straints were then introduced and the receptor was subjected
to a series of simulated annealing simulations with appro-
priate distance and dihedral angle constraints. Secondary
structure information was obtained from applications of
prediction methods and by searching for structural tem-
plates in the PDB database (Berman et al., 2000).
Secondary structure propensities were obtained by com-
paring predictions from seven major algorithms, as pro-
vided by the Protein Structure Prediction (PELE) module of
the Biology Workbench (http://workbench.sdsc.edu). Struc-
ture was assigned based on the joint prediction for each
amino acid. Database searches included seven amino acids
at either ends of the loop region to allow stemming of the
loops from the helix ends. The searches produced from 3 to
14 hits for each of the loops investigated. In the majority of
cases, sequence homology searches produced hits for only
portions of the loops, with the average length of the frag-
ment being 11 5 residues. Interestingly, the matches were
from either loops or solvent-exposed regions of their re-
spective x-ray structures. The fragments found by the data-
base search were also used to confirm or reject the second-
ary prediction results. If agreement was found, dihedral
angle constraints were added to restrict the matched regions
to either the -helical or 
-sheet conformation during the
simulations.
Application of secondary structure prediction to the 32-
residue N-terminal region produced an extended conforma-
tion for residues 9 to 14 and a helical conformation for
residues 26 to 31. Searches for sequence homologs pro-
duced fragments from 14 unique PDB structures. Segments
that matched residues 26–31 were found to be helical (2 of
2 structures). Region 9–14 was matched by structures con-
taining amino acid classified as being either in an extended
or bend region (4 structures) and it was modeled as an
extended structure based on secondary structure prediction.
The remaining residues of the N-terminus mostly matched
unstructured segments and the dihedral angles of such res-
idues were not constrained during the simulations. Two
prolines, P34 and P35, introduce a helix break between the
predicted N-terminus 26–31 helix and TM1.
The first extracellular loop, connecting TM2 with TM3,
comprises residues Y89 to M100 of the model. Application
of the prediction algorithm resulted in an extension of the
TM2 helix to A91. It also showed that the W94DFGNT99
region was unstructured. Databases searches resulted in one
hit for region F85-A91, corresponding to a helical fragment
and three matches for W94-T99 corresponding to either coil
or bend regions of these proteins. The loop structures varied
greatly among the three hits and dihedral angle constraints
were not applied to the W94-T99 fragment of EL1.
The disulfide bridge between C101 and C178 (Blanpain
et al., 1999b) separates EL2 in two segments, with the
N-terminal residues linking TM3 and TM4, while residues
C-terminal from C178 connect TM4 to TM5 (Fig. 1). Ho-
mology searches did not produce clear secondary structure
preference when searches were done either on the entire
EL2 region or only the N-terminal or C-terminal fragments.
Application of homology searches and prediction methods
to EL3 resulted in a helical conformation for the
L275DQAMQ280 fragment, thus extending the TM7 helix
into the extracellular domain by six residues. The database
search provided four hits for the L275-Q280 region, three of
which were helical. Residues 261–274 of EL3 were
matched by four fragments, all of which were in loop
regions of these proteins.
Because of the scarcity and limited match of the database
results, the fragments were used to generate initial templates
and loop optimization was carried out using a constrained
simulated annealing protocol. Loops were inserted one at
the time by choosing conformations free of steric overlap
among the different regions. Dihedral angle constraints
were used to restrain the residues to the predicted secondary
structures during the simulated annealing procedure. Ter-
tiary constraints were added in the form of distance con-
straints between residues in different loops, based on avail-
able epitope mapping results, summarized in Table 4.
Distance constraints r  15 Å were used between the C
atoms of epitope residues (Burritt et al., 1998). Constraints
were applied between N-terminal residues (region 1–13)
and EL2 (residues 168, 176–177), and between EL1-D95
and K171-E172 in EL2. A more generous constraint of r 
25 Å was added between the C atoms of D95 and those of
residues 1–13 of CCR5 to account for the observed inter-
action between the first 13 amino acids of the N-terminus
and D95 (Hill et al., 1998). Specific side chain-side chain
interactions were not obtained in that study. The 25 Å cutoff
corresponds to the average diameter of a globular protein of
the same size as the extracellular domain of CCR5 (Harpaz
et al., 1994). This cutoff assumes that the observed sensi-
tivity upon mutation of D95 may arise not only from direct
side chain-side chain contact, but also from structural
changes in the globular fold of these regions. As shown in
rhodopsin, the EC domains of GPCRs are likely to form a
compact folding motif. By comparison, the EC domain of
rhodopsin is similar in length to that of CCR5 and the
distance between EL1 and the first 13 N-terminus residues
varies between 15 and 25 Å. The 25 Å distance con-
straint between the N-terminus and EL1 simply imposes
compactness between these two regions, without creating
specific residue pair interactions that are not available at this
time. The set of geometrical constraints for the 95-residue
extracellular domain consisted of a total of 29 distance
constraints and 124 (, 	) dihedral angle constraints
(Table 4).
The three intracellular loops of CCR5 range from 6 to 10
residues in length (Fig. 1). Residues in IL1 were modeled
after rhodopsin, whose sequence homology with CCR5 is
83%. The second and third loops, however, have either low
homology or differ in length from those of rhodopsin. These
loops were therefore modeled by searching through a loop
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database for segments with similar end-end distance (In-
sightII, 2002. Accerlys Inc., San Diego, CA). The receptor
model was terminated after helix 8 (Palczewski et al., 2000),
which has high homology with rhodopsin. Residues 302 to
352 were not modeled because of low homology to rhodop-
sin and lack of experimental data. Initial loop structures
were then subjected to a simulated annealing protocol, as
described in the Methods.
The accuracy of modeled loop structures is typically
assessed against the actual x-ray structure of the test pro-
teins (Fiser et al., 2000). Unfortunately, such comparison is
not possible for CCR5, because of the poor homology with
rhodopsin in the extracellular domains. A previous study of
single loops by Fiser et al. (2000) has shown that, given an
adequate sampling of the conformational space, the quality
of the structures can be inferred from 1) the correlation
between the energy of the models and the RMSD, and 2) by
the low structural variability among the low-energy struc-
tures. These two criteria were used here in the analysis of
the simulated EC domains.
The bell-shaped energy profile of the simulated structures
(Fig. 6 A) indicates statistically significant sampling of the
conformational space. A plot of the RMSD from the lowest
energy structure versus energy gave a Pearson coefficient
TABLE 4 Geometrical constraints used in modeling simulations of the extracellular loop regions*
Residues*
Distance# and dihedral angle
constraints§ Reference
N-terminus M1DYQVSSPIYDIN13 C(D95)-C(M1-Y13)  25 Å Hill et al., 1998
I9YDINY14 E
C20 S-S bond with C269
K26QIAARL32 H
D2YQ4, S7P8, N13 C(X)-C(Y176)  15 Å Olson et al., 1999
C(X)-C(T177)  15 Å Olson et al., 1999
D2 C(D2)-C(R168)  15 Å Olson et al., 1999
EL1 D95 C(D95)-C(K171)  15 Å Lee et al., 1999
C(D95)-C(E172)  15 Å Lee et al., 1999
C(D95)-C(M1-Y13)  25 Å Hill et al., 1998
C101 S-S bond with C178
EL2 R168 C(D2)-C(R168)  15 Å Olson et al., 1999
K171 C(D95)-C(K171)  15 Å Lee et al., 1999
E172 C(D95) C(E172)  15 Å Lee et al., 1999
Y176 C(X)-C(Y176)  15 Å Olson et al., 1999
T177 C(X)-C(T177)  15 Å Olson et al., 1999
C178 S-S bond with C101
EL3 L275DQAMQ280 H
C269 S-S bond with C20
*Residues are denoted by their one-letter code. Subscripts indicate the residue number of the first and last residue in the fragments.
#C(X) denotes the C atom of the residues D2YQ4, S7P8, N13.
§H  (  65°, 	  40°), E  (  115°, 	  135°). Additional conformational constraints were   0 for all residues except Gly and  
180° for non-Pro residues.
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r  0.42 (Figure 6 B). The backbone atoms of the TM
regions and EC domains were used in the superimposition.
Structural variability was calculated as the average RMSD
of the nine structures with the lowest conformational ener-
gies. Fig. 7 shows two low-energy structures representative
of low variability (E  398.8 kcal/mol) and high vari-
ability (E  384.2 kcal/mol). Variability was small for
five of these structures, suggesting that one dominant native
conformation may have been obtained from the simulations
(E  398.8 kcal/mol in Fig. 7). However, the two criteria
for assessing the quality of the EC domains are only par-
tially fulfilled by the modeled structure because of the
weak-to-moderate correlation between energy and RMSD,
and the presence of low-energy conformations with high
variability (Fig. 6, inset).
When each EC domain was superimposed individually,
rms deviations from the mean coordinates ranged up to 9 Å
for the N-terminus, 5 Å for EL1, 7 Å for EL2, and 6 Å for
EL3. The structures were then clustered based on structural
similarity to find major structural groups. RMSD cutoffs
were increased from 2.0 Å until a significant number of
structures were represented in each cluster. Clustering of
EL1 structures with a 3.5 Å cutoff resulted in 60% of the
structures in six clusters containing 14 to 53 loops each.
About 50% of EL2 structures were found in nine clusters
with 9 to 18 structures each when using a 6.5 Å cutoff. Fifty
percent of the EL3 structures clustered in eight groups
containing 9 to 27 structures each. Clustering of the N-
terminus structures with a 7 Å cutoff resulted in 30% of the
structures in five clusters containing 17 to 23 structures
each. Results show that, with the exception of the shorter
EL1, the clusters contain structures with large structural
variations among them.
I further analyzed the simulated structures in terms of
their average properties to capture global characteristics that
may not be apparent from either the lowest energy struc-
tures or individual loop conformations. Commonalities in
the global fold of the EC domains were found by examining
average properties of solvent accessibility and frequency of
contact interactions among the domains.
The solvent-accessible surface area of the EC amino
acids, averaged over the 250 structures, is shown in Fig. 8
A. Approximately 60% of the N-terminus residues have
solvent accessibility 40%. On the contrary, EL3 is clearly
the most buried of the loops. The disulfide bridge between
C101 and C178 limits the solvent accessibility of six resi-
dues near C178 in EL2, where, on average, the C-end of this
loop is more solvent-exposed than its N-end portion. The
low accessibility of D95 in EL1 arises from interaction of
this side chain with residues of the N-terminus.
The 250 structures were also evaluated based on interac-
tion of hotspot residues, defined here as residues of the loop
regions whose mutation results in loss of binding for either
chemokines or gp120. As shown in Table 5, hotspot resi-
dues consist of mostly acidic and aromatic amino acids in
the N-terminus, EL2, and EL3. The environment of these
crucial residues was characterized by selection of the inter-
acting residues from the set of the 250 structures (Fig. 8 B).
The majority of the models showed interactions of EL1 with
hotspot residues located in the N-terminus (D2-I12 and
Y14-E18) and EL2 (Y176-T177). The second extracellular
loop presented interactions with the D2-I12 fragment of the
N-terminus. Close contacts between the Y14-E18 segment
and EL3 originate from the disulfide bond between C20 and
C269. Residues at either the C-end of the N-terminus (K26
and R31) or F263-N267 of EL3 did not show significant
interaction with the other extracellular regions.
By comparison, simulations performed without the addi-
tion of tertiary distance constraints completed lacked inter-
actions among the four domains, except in the immediate
proximity of the two disulfide bonds. The four domains did
not assemble into a compact fold, and several structures
were found where the domains packed against the 7-TM
helices. Such conformations are unrealistic in the membrane
environment. They appear because the simulated annealing
protocol has to be carried out in vacuo, thus ignoring the
lipid environment of the TM helices.
DISCUSSION
The x-ray structure of rhodopsin provides the template for
models of the homologous GPCR. However, the specific
sequence motifs of rhodopsin give rise to local distortions of
the 7-TM helices that may not be present in other receptors.
Deviations from the standard helical conformation result in
a different orientation of the helices in the bundle and
changes in the shape and amino acid composition of the
GPCR binding pocket. Specific structural motifs may also
provide a mechanism of receptor activation. Recently, Go-
vaerts et al. (2001a) have investigated the role of the
T82VP84 motif in TM2 of CCR5 in receptor activation. A
P84A mutation resulted in decreased affinity for chemo-
kines, while mutations of T72 impaired receptor activation
following binding of chemokines. In that work, the helix
bent at P84 was correlated with the activation process. In
this work, I have found that the helical distortion in TM2 of
rhodopsin is characteristic of Gly-containing helices in in-
terfacial regions (Javadpour et al., 1999), resulting in tight
packing with TM3. The Gly motif of rhodopsin was then
replaced in CCR5 with a motif derived from Pro-containing
helices (Ne´mety et al., 1992; Sankararamakrishnan and
Vishveshwara, 1992) and residues at the C-terminal end of
TM2 were oriented based on sequence conservation in a set
of 50 sequences homologous to CCR5. The resulting helix
kink orients the CC-chemokine conserved tryptophan
(W86) in the binding pocket, in an orientation similar to that
modeled by Govaerts et al. (2001a). Unlike the changes in
TM2, helix 5 of CCR5 was modeled after rhodopsin with a
bulge in the L203-V209 region. The TM5 and TM7 rho-
dopsin templates were maintained based on sequence com-
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dopsin and consideration of sequence homology and exper-
imental data on closely related receptors.
Receptors in Table 1 share the highest sequence homol-
ogy with CCR5. Highly conserved residues line the bottom
of receptor cavity (Fig. 3 B), where they form a tight
network of interacting side chains. These amino acids com-
prise the highly conserved “fingerprint” residues character-
istic of the rhodopsin-GPCR family (Attwood and Findlay,
1994). It was surprising, however, to find few additional
residues shared across receptors classes. Only the angioten-
sin receptors had residues in common with CC-chemokines
(P34 (1.36), W86 (2.60), and C290 (7.46) of CCR5). CCR5
shares six residues with receptors CCR1 to CCR4 (Fig. 3 B).
Two conserved aromatic clusters characterize the cavity in
these receptors (Fig. 2). Four aromatic residues, TM1-Y37
(1.39), TM2-W86 (2.60), TM3-Y108 (3.32), and TM6-
Y251 (6.51), are within an 6 Å radius from the acidic
residue TM7-E283. The second aromatic cluster is adjacent
to the first one and includes the highly conserved Y244
(6.44) and W248 (6.48) in TM6 and the CC-chemokine-
specific residues TM2-F79 (2.53) and TM7-H289 (7.45).
Therefore, the receptor cavity of receptors CCR1 through
CCR5 utilizes class-specific aromatic residues for side
chain interactions with the “fingerprint” residues of GPCR
(Y244 and W248 in CCR5). Given the implication of these
residues in receptor activation (Javitch et al., 1998), their
interaction with the conserved aromatic cluster could serve
as a common mechanism of activation in proteins CCR1 to
CCR5.
Site-directed mutagenesis studies have characterized the
binding mode of the CCR5 antagonist TAK-779 (Dragic et
al., 2000). Single point mutations of residues L33, Y37,
W86, Y108, and E283 to Ala decreased the efficacy of
TAK-779 in antagonizing the binding of gp120 to CCR5.
Our molecular docking simulations show that all of the
above residues are part of TAK779 binding site (Dragic et
al., 2000) (Fig. 5 and Table 3). In particular, the docking
orientation is characterized by an electrostatic interaction
between the ammonium group of TAK779 and E283. This
glutamate is conserved in receptors CCR1 through CCR5, it
is solvent-accessible (Fig. 3 B), and it is the only acidic
residue in the extracellular end of the 7-TM bundle. Mu-
tagenesis data have shown the importance of this glutamate
not only for the binding of TAK779, but for antagonists of
other CC-chemokine receptors as well. Recent mutagenesis
data on CCR2 showed loss of binding of basic spiropiperi-
dine ligands upon mutation of Glu to either alanine or
glutamine (Mirzadegan et al., 2000). Correspondingly, quat-
ernization of the piperidine nitrogen has been shown to be
essential for the high affinity of CCR1 antagonists (Liang et
al., 2000; Naya et al., 2001). Given that small ligands of
CC-chemokine receptors are characterized by a basic amino
group (Liang et al., 2000; Ng et al., 1999; Sabroe et al.,
2000), it is plausible that receptors CCR1 through CCR5
share a common binding mode characterized by an electro-
static interaction with the conserved TM7-glutamate. Addi-
tional interactions of TAK779 with residues in TM5 and
TM6 find partial agreement with the mutagenesis data (Ta-
FIGURE 7 Schematic diagram of two representative low energy structures of the EC domains. Hotspot residues are shown in a stick representation.
Orange: N-terminus; cyan: EL1; green: EL2; magenta: EL3.
FIGURE 6 Analysis of the extracellular loop regions. (A) Histogram of the conformational energy distribution of the 250 structures generated by the
simulated annealing procedure. Energies were binned at 10 kcal/mol. (B) Energy plot versus RMSD from the lowest energy structure (E  398.9
kcal/mol). The straight line is the least-square fit (Pearson coefficient  0.42). Inset: the average rms deviation, of the nine low-energy structures. The
RMSD is calculated from the average of (9  8)/2 pairwise RMSDs.
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ble 3). The residues involved are small (T195) or hydro-
phobic (L104, F112, and L255). It is plausible that their
substitution with Ala may perturb the binding energy less
than the replacement of charged or polar aromatic residues.
FIGURE 8 Analysis of the extracellular loop regions. (A) Average solvent accessibility surface areas of the extracellular regions of CCR5. Values
represent the average over 250 structures generated by the simulated annealing procedure. (B) Interactions between hotspots residues, defined in Table 5,
and the three extracellular loops. Normalized values indicate the probability that a given residue of the EC regions is within 5 Å of hotspot residues. Graphs
were generated using the 250 structures obtained from the simulated annealing procedure.
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Similarly, loss of opioid receptor affinities is greatest upon
mutation of a critical Asp and nearby polar aromatic resi-
dues, while mutations of hydrophobic groups have smaller
effects (Surratt et al., 1994; Befort et al., 1996; Metzger et
al., 2001).
The docking mode of TAK779 (Fig. 5), while in agree-
ment with the experimental data, differs from a previous
orientation proposed from the analysis of these same data
(Dragic et al., 2000). It has been previously suggested that
the methyl-benzyl-heptadyl moiety binds among TM1,
TM2, and TM7, while the positively charged ammonium
group would orient toward the extracellular domain (Dragic
et al., 2000). Automated docking simulations were not per-
formed in that study. The proposed binding mode of
TAK779 presented here is validated by the integration of
systematic docking simulations together with mutagenesis,
SAR, and sequence analysis.
The binding mode of TAK779 accounts for receptor
affinity, but also shows that the above six residues are not
unique to CCR5, as they are also found in CCR1 and CCR2,
two receptors with low affinity for TAK-779 (Baba et al.,
1999). Therefore, the selectivity of TAK-779 for CCR5
must derive from nonconserved side chains, such as those in
Fig. 3 B. This hypothesis was tested by performing docking
simulations of TAK779 to CCR1 and CCR2. Several dock-
ing orientations contained interaction of the ammonium
nitrogen with the conserved glutamate in TM7, but the
4-methyl-benzocyloheptenyl group of TAK779 docked
close to the extracellular end of the 7-TM bundle. We find
that substitution of CCR5 amino acids with bulkier side
chains in CCR2 and CCR1 is responsible for lack of binding
deep in the TM pocket. Such residues are R206, F116, and
Y124 in CCR2, and Y104 and Y118 in CCR1.
The docking results, when combined with current mu-
tagenesis data and SAR on CCR5 and other CC-chemokine
receptors (Dragic et al., 2000; Liang et al., 2000; Mirzade-
gan et al., 2000; Naya et al., 2001) suggest a common
binding mode for CC-chemokine antagonists. Conserved
regions of CC-chemokine receptors (i.e., L33 (1.35), Y37
(1.39), W86 (2.60), Y108 (3.32), and E283 (7.39) in CCR5)
bind the common chemical component of chemokines an-
tagonists, i.e., the basic nitrogen of the piperidine ring,
while residues in TM3, TM5, and TM6 interact with aro-
matic moieties of these molecules (the methyl-benzyl-hep-
tadyl moiety in CCR5). The proposed binding mode, where
conserved regions of receptors bind conserved chemical
motifs of ligands, finds similarities with that of other GPCR,
for example opioid and dopamine receptors (Simpson et al.,
1999; Metzger et al., 2001; McFadyen et al., 2001). Exten-
sive mutagenesis studies and docking studies of those two
receptor classes has shown that a highly conserved Asp in
TM3 (3.32) is responsible for the binding of the basic amino
group of aminergic and opioid ligands, while divergent
chemical moieties bind nonconserved amino acid residues.
While the conserved Asp (3.32) is responsible for a large
portion of the binding energy in the majority of aminergic
and opioid receptors, the contribution of the nonconserved
residues to binding was found only after extensive mutagen-
esis studies. The proposed binding mode for CC-chemokine
antagonists can be used to guide further experimental stud-
ies to better define the interactions of TAK-779 with the
nonconserved residues in TM5 and TM6.
Binding of TAK779 to CCR1 and CCR2 is likely to
include residues of the EC regions, whose steric and elec-
trostatic interactions give rise to poor affinity (CCR2) or
lack of binding (CCR1). The likelihood that the EC region
of CCR5 could interfere with the binding of the antagonist
was investigated by pooling residues within a 5 Å radius of
Y37, W86, and E278 from the set of 250 EC structures
obtained by simulated annealing. Only 5% of the structures
TABLE 5 Residues implicated in the interaction of CCR5 with either MIP-1 or dual-tropic HIV virus, as obtained from
site-directed mutagenesis data
Extracellular
Location
Residue
Number
% Loss of MIP-
1-
 Binding
% Loss of Dual-Tropic
HIV Virus Binding Reference
N-terminus D2 100 100 Blanpain et al., 1999a
Y3 100 60 Blanpain et al., 1999a
Y10 100 100 Blanpain et al., 1999a
D11 100 90 Blanpain et al., 1999a
I12 100 100 Blanpain et al., 1999a; Howard et al., 1999
Y14 100 Rabut et al., 1998
Y15 100 Rabut et al., 1998
S17 80 Rabut et al., 1998
E18 100 80 Blanpain et al., 1999a
K26 100 Zhou et al., 2000
R31 70 Zhou et al., 2000
EL2 Y176 50 Genoud et al., 1999
T177 60 Genoud et al., 1999
El3 F263 50 Genoud et al., 1999
F264 50 Genoud et al., 1999
N267 50 Genoud et al., 1999
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had interactions between the binding pocket residues and
either EL1 or EL2. Interactions with EL3 were found in
30% of the structures and centered on Q261 and the N273-
Q277 region. These results are in agreement with the ex-
perimental findings (Dragic et al., 2000) that mutations of
EL1 and EL2 residues have no effect on TAK779 binding,
and Q261A, N273A-Q277A mutations mildly decreased the
ability of TAK779 to interfere with gp120 binding. The
results therefore exclude a contribution of the loops to the
binding of TAK779 to CCR5.
I have used segment-matching (Sanchez and Sali, 1999)
in combination with secondary prediction methods to gen-
erate structural templates and dihedral angle constraints of
the four extracellular domains. The database searches pro-
vided segments that could be superimposed to generate an
initial template. Typically, each loop was reconstructed by
matching three to four overlapping segments. Given the
geometrical variability of the CCR5 loops, it is unlikely that
the matches found for CCR5 are a unique representation of
the conformation of the EC domains. Therefore, I have
chosen to use the database searches not for obtaining an
actual structural template, but to uncover regions where
regular secondary structure motifs may occur. Such regular
structures occur in rhodopsin (Palczewski et al., 2000),
where the N-terminus and EL2 assemble into 
-sheet folds,
and have been postulated to exist in other receptors as well
(Paterlini et al., 1997; Moro et al., 1999; Zhang et al.,
2002b). A previous modeling study of EL2 of the -opioid
receptor based on database matches and secondary predic-
tion (Paterlini et al., 1997) has been recently validated by
NMR spectroscopy of this loop in a DPC micelle (Zhang et
al., 2002b).
The conformational freedom of the individual loops was
restricted by application of dihedral angle constraints based
on both the predicted and observed secondary structure
propensities when available. Tertiary interactions, in the
form of distance constraints between different structural
domains, were added from considerations of available
epitope mapping results. A simulated annealing protocol
was then used to generate loop models that were analyzed
based on conformational energy criteria, conformational
variability, and average physical properties. The set of
150 dihedral and geometrical constraints used in the sim-
ulations was not sufficient for complete structural determi-
nation of the 95 residues of EC domains. Loop conforma-
tions, when clustered according to their RMSD, showed
structural variability from 3.5 Å for EL1 to 7 Å for the
N-terminus. However, the distance constraints between the
EC loops were necessary to maintain a compact fold of the
four regions. Simulations carried out without the addition of
tertiary distance constraints resulted in improbable struc-
tures void of interactions among the EC domains where the
longer loops and the N-terminus packed against the hydro-
phobic TM helices.
Criteria used to assess the quality of modeled loops have
limited applicability to CCR5 because of the length of the
loops and interactions among the domains. I have estimated
the accuracy of the simulated EC domains from the corre-
lation between the conformational energy and RMSD and
from the conformational variability of the low-energy con-
formations. This approach has been previously tested on
single loops up to 12 residues in length (Fiser et al., 2000),
and it is applied here to a considerably more complex
system. I find a low-to-moderate correlation and low vari-
ability of some of the structures, those suggesting that a
dominant low energy conformation has been found (Fig. 7).
The quality of the correlation and variability is likely to
improve by either increasing the number of constraints or,
alternatively, by applying stricter distance constraints. How-
ever, available biological data suggested only a range of
interacting residues (as between D95 and the N-terminus),
thus making it necessary to adopt distance cutoffs that are
not biased toward specific residue-residue interactions.
The binding of chemokine and gp120 has been exten-
sively probed by site-directed mutagenesis of residues in the
EC regions (Table 5). Single-point mutations can either
eliminate essential side chains interactions with ligands, or
perturb the tertiary structure of the EC domains. If the
models can distinguish between the two cases we can utilize
them to guide experimental design.
Average properties of the modeled EC regions were used
to obtain common folding characteristics and pattern of
interacting residues. The average solvent accessibility area
(Fig. 8 A) reflects, in part, the geometrical constraints im-
posed by the disulfide bonds and between the N-terminus
and EL2. The lower accessibility of EL3 is likely due to the
disulfide bond between C20 and C269, which causes the
N-terminus to lie directly above EL3 (Fig. 7). The obser-
vation that it has not been possible to raise monoclonal
antibodies against EL3 (Lee et al., 1999) finds support in
low solvent accessibility of EL3 in the current model. On
the contrary, the C-terminal region of EL2 has clearly high
solvent accessibility (Fig. 8 A), in agreement with the find-
ing that several mAbs can recognize epitopes in this region
(Lee et al., 1999).
Structures characteristic of major structural clusters show
commonalities, despite the great variability among them. As
illustrated in the case of low-energy structures (Fig. 7), the
N-terminus cuts across the EC domain to reach EL2 thus
separating EL1 from EL3. The interactions between the
N-terminus and the three loops give rise to clusters of
hotspot aromatic and acidic residues such as with D95 in
EL1, Y176-T177 in EL2, and C269 in EL3 (Figs. 8 B).
Some of the hotspot residues were also part of the epitope,
and as such subjected to distance constraints (Table 4).
However, the cutoffs used in the simulations were three to
fivefold greater than the one used to identify close contacts
(d  5 Å) and individual residue contacts were not speci-
fied. Many of the hotspot residues are also characterized by
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low average solvent accessibility because they are involved
in side chain-side chain interactions, such as D2, D95,
R168, Y176, and T177. I suggest that the loss of binding
observed for mutations at these loci originate from a per-
turbation of the tertiary organization of the EC regions. In
contrast, regions such as the C-terminal end of the N-
terminus and residues F263-N267 in EL3 both lack specific
interactions and are solvent-accessible (Fig. 8, A and B). I
propose that the observed loss of binding upon mutagenesis
in these regions originates from a direct loss of interactions
with chemokines or gp120. Gain-of-function studies where
the affinity of CCR5 is restored by complementary replace-
ment or swapping of residue pairs (Zhou et al., 1994;
Govaerts et al., 2001b) could be used to validate side chain
interactions obtained in the study. For example, experiments
could involve residue pairs such as N-term-D2 and EL2-
R168, N-term-N13 and EL1-D95, or N-term-E18 and EL3-
R274. Putative sites of chemokines interaction outlined here
may also be used to map the molecular determinants of
RANTES recognition (Nardese et al., 2001) onto the surface
of the EC models. For example, the clusters of negatively
charged residues can be used to orient RANTES on the EC
surface by matching the complementary basic clusters of
this chemokines in docking simulations.
CONCLUSIONS
Presently, GPCRs can be modeled from rhodopsin, the only
member of this family for which the x-ray structure has
been resolved. The usefulness of these homology models
greatly depends on their ability to explain and predict the
binding of their endogenous ligands and to efficiently aid
the discovery of new synthetic compounds. Sensitivity of
the 7-TM template to local distortions, imparted by se-
quence-specific motifs, can affect the size and nature of the
binding cavity. The difficulty in obtaining structural data of
the loop regions based on sequence homology makes it
arduous to structurally characterize these regions, despite
their importance in binding and recognition, as exemplified
by CCR5.
I have presented a comprehensive model of CCR5 that
elucidates the binding of both small ligands and its sensi-
tivity to mutations for binding of chemokines and the coat
protein gp120 of HIV-1. The computational approach has
sought to enhance homology-modeling techniques with ab
initio simulations and knowledge-based information to gen-
erate structural models that are then corroborated by com-
parison with additional data. The model of the transmem-
brane region was validated by probing the binding of
TAK779 using automated docking simulations. The dock-
ing mode finds support in available experimental data and
specific hypotheses have been formulated to explain both
affinity and selectivity of TAK-779 for CCR5. Application
of evolutionary tracing to the 7-TM region readily identifies
CC-conserved residues, such as E283 and aromatic residues
in TM1, TM2, and TM3, that create a CC-chemokine class-
specific receptor pocket. Correlation of the conserved glu-
tamate with the presence of a quaternary ammonium group
in current CC-chemokine antagonists further suggests com-
monalities in the binding of CCR1-CCR5 that can be ex-
ploited when designing small ligands for these receptors.
The size and complexity of the EC regions examined here
required that supplementary constraints be added during
modeling, in addition to knowledge-base information on the
secondary structure of the individual loops. These were
obtained in the form of tertiary constraints based on the
epitope mapping studies. Analysis of the average properties
of the simulated structures suggests different roles for the
functionally important residues, as either maintaining the
tertiary structure of the EC domain, or as being accessible to
binding by chemokines or gp120. The constrained simu-
lated annealing protocol, in combination with conforma-
tional clustering, provides a systematic approach for gener-
ating low-resolution structures of EC domains for further
experimental validation and design.
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